The clinical effect of dietary supplementation with omega-3 fish oils and/or copper in systemic lupus erythematosus

EM Duffy, GK Meenagh, SA McMillan, JJ Strain, BM Hannigan, AL Bell

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Objective. To determine the effect of dietary supplementation with omega-3 fish oils with or without copper on disease activity in systemic lupus erythematosus (SLE). Fish oil supplementation has a beneficial effect on murine models of SLE, while exogenous copper can decrease the formation of lupus erythematosus cells in rats with a hydralazine-induced collagen disease. Methods. A double blind, double placebo controlled factorial trial was performed on 52 patients with SLE. Patients were randomly assigned to 4 treatment groups. Physiological doses of omega-3 fish oils and copper readily obtainable by dietary means were used. One group received 3 g MaxEPA and 3 mg copper, another 3 g MaxEPA and placebo copper, another 3 mg copper and placebo fish oil, and the fourth group received both placebo capsules. Serial measurements of disease activity using the revised Systemic Lupus Activity Measure (SLAM-R) and peripheral blood samples for routine hematological, biochemical, and immunological indices were taken at baseline, 6, 12, and 24 weeks. Results. There was a significant decline in SLAM-R score from 6.12 to 4.69 (p < 0.05) in those subjects taking fish oil compared to placebo. No significant effect on SLAM-R was observed in subjects taking copper. Laboratory variables were unaffected by either intervention. Conclusion. In the management of SLE, dietary supplementation with fish oil may be beneficial in modifying symptomatic disease activity.
LanguageEnglish
Pages1551-1556
JournalJournal of Rheumatology
Volume31
Issue number8
Publication statusPublished - Aug 2004

Fingerprint

Fish Oils
Dietary Supplements
Systemic Lupus Erythematosus
Copper
Placebos
Collagen Diseases
Hydralazine
Capsules

Cite this

@article{2cf4cf01c1c743e691d6e4b6d993d201,
title = "The clinical effect of dietary supplementation with omega-3 fish oils and/or copper in systemic lupus erythematosus",
abstract = "Objective. To determine the effect of dietary supplementation with omega-3 fish oils with or without copper on disease activity in systemic lupus erythematosus (SLE). Fish oil supplementation has a beneficial effect on murine models of SLE, while exogenous copper can decrease the formation of lupus erythematosus cells in rats with a hydralazine-induced collagen disease. Methods. A double blind, double placebo controlled factorial trial was performed on 52 patients with SLE. Patients were randomly assigned to 4 treatment groups. Physiological doses of omega-3 fish oils and copper readily obtainable by dietary means were used. One group received 3 g MaxEPA and 3 mg copper, another 3 g MaxEPA and placebo copper, another 3 mg copper and placebo fish oil, and the fourth group received both placebo capsules. Serial measurements of disease activity using the revised Systemic Lupus Activity Measure (SLAM-R) and peripheral blood samples for routine hematological, biochemical, and immunological indices were taken at baseline, 6, 12, and 24 weeks. Results. There was a significant decline in SLAM-R score from 6.12 to 4.69 (p < 0.05) in those subjects taking fish oil compared to placebo. No significant effect on SLAM-R was observed in subjects taking copper. Laboratory variables were unaffected by either intervention. Conclusion. In the management of SLE, dietary supplementation with fish oil may be beneficial in modifying symptomatic disease activity.",
author = "EM Duffy and GK Meenagh and SA McMillan and JJ Strain and BM Hannigan and AL Bell",
year = "2004",
month = "8",
language = "English",
volume = "31",
pages = "1551--1556",
journal = "Journal of Rheumatology",
issn = "0315-162X",
number = "8",

}

The clinical effect of dietary supplementation with omega-3 fish oils and/or copper in systemic lupus erythematosus. / Duffy, EM; Meenagh, GK; McMillan, SA; Strain, JJ; Hannigan, BM; Bell, AL.

In: Journal of Rheumatology, Vol. 31, No. 8, 08.2004, p. 1551-1556.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The clinical effect of dietary supplementation with omega-3 fish oils and/or copper in systemic lupus erythematosus

AU - Duffy, EM

AU - Meenagh, GK

AU - McMillan, SA

AU - Strain, JJ

AU - Hannigan, BM

AU - Bell, AL

PY - 2004/8

Y1 - 2004/8

N2 - Objective. To determine the effect of dietary supplementation with omega-3 fish oils with or without copper on disease activity in systemic lupus erythematosus (SLE). Fish oil supplementation has a beneficial effect on murine models of SLE, while exogenous copper can decrease the formation of lupus erythematosus cells in rats with a hydralazine-induced collagen disease. Methods. A double blind, double placebo controlled factorial trial was performed on 52 patients with SLE. Patients were randomly assigned to 4 treatment groups. Physiological doses of omega-3 fish oils and copper readily obtainable by dietary means were used. One group received 3 g MaxEPA and 3 mg copper, another 3 g MaxEPA and placebo copper, another 3 mg copper and placebo fish oil, and the fourth group received both placebo capsules. Serial measurements of disease activity using the revised Systemic Lupus Activity Measure (SLAM-R) and peripheral blood samples for routine hematological, biochemical, and immunological indices were taken at baseline, 6, 12, and 24 weeks. Results. There was a significant decline in SLAM-R score from 6.12 to 4.69 (p < 0.05) in those subjects taking fish oil compared to placebo. No significant effect on SLAM-R was observed in subjects taking copper. Laboratory variables were unaffected by either intervention. Conclusion. In the management of SLE, dietary supplementation with fish oil may be beneficial in modifying symptomatic disease activity.

AB - Objective. To determine the effect of dietary supplementation with omega-3 fish oils with or without copper on disease activity in systemic lupus erythematosus (SLE). Fish oil supplementation has a beneficial effect on murine models of SLE, while exogenous copper can decrease the formation of lupus erythematosus cells in rats with a hydralazine-induced collagen disease. Methods. A double blind, double placebo controlled factorial trial was performed on 52 patients with SLE. Patients were randomly assigned to 4 treatment groups. Physiological doses of omega-3 fish oils and copper readily obtainable by dietary means were used. One group received 3 g MaxEPA and 3 mg copper, another 3 g MaxEPA and placebo copper, another 3 mg copper and placebo fish oil, and the fourth group received both placebo capsules. Serial measurements of disease activity using the revised Systemic Lupus Activity Measure (SLAM-R) and peripheral blood samples for routine hematological, biochemical, and immunological indices were taken at baseline, 6, 12, and 24 weeks. Results. There was a significant decline in SLAM-R score from 6.12 to 4.69 (p < 0.05) in those subjects taking fish oil compared to placebo. No significant effect on SLAM-R was observed in subjects taking copper. Laboratory variables were unaffected by either intervention. Conclusion. In the management of SLE, dietary supplementation with fish oil may be beneficial in modifying symptomatic disease activity.

M3 - Article

VL - 31

SP - 1551

EP - 1556

JO - Journal of Rheumatology

T2 - Journal of Rheumatology

JF - Journal of Rheumatology

SN - 0315-162X

IS - 8

ER -